– Neuroendocrine Cancer UK is thrilled to announce an upcoming Webi-Natter event focused on the recent news of NICE’s approval of SIRT Therapy for neuroendocrine tumours. Scheduled for May 30th from 6:00pm to 7:30pm (GMT), this event will delve into the...
– Launch of Rareminds Wellbeing Hub and Release of “Rare Minds Matter – Rare Disease and Mental Health 2023 Survey Results” We are thrilled to announce the launch of the Rareminds Wellbeing Hub, a vital resource designed to help individuals...
We are delighted to share with you the news that NICE has recommended SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour-related liver metastases. NICE Interventional procedures guidance [IPG786]: Selective internal radiation...
At Neuroendocrine Cancer UK we want to ensure we continue to meet your needs and support you in the way you want to be supported. Please complete our survey to allow us to do this. It will take about 15 minutes. Your feedback is so important to us because it...
CommonGround Online Peer Support in Long-Term Conditions: A team at King’s College London has collaborated with individuals living with long-term physical health conditions to develop a new online peer support platform. They are eager to gather feedback on the new...
